⚡ Syringe Tool
Metabolic & Fat Loss Phase 3 Clinical Trials PubChem CID: 162031264

Cagrilintide: Clinical Mechanism, Dossier & Protocols

Long-acting synthetic amylin analogue acylated for once-weekly subcutaneous dosing; works via distinct non-GLP neural pathways to trigger powerful early satiety and delayed gastric emptying.

Reconstitution Guide Syringe Calculator BAC Water Guide

🔬 Molecular Architecture & Physical Specifications

Molecular Weight
4502.8 g/mol
Chemical Formula
C191H307N49O59S
CAS Registry Number
1415456-99-3
Elimination Half-Life
Approx. 7-8 days
Administration Route
Subcutaneous (SC)
NCBI PubChem Record
Amino Acid Sequence: Non-selective amylin/calcitonin receptor agonist with albumin-binding fatty acid moiety

⚙️ Primary Mechanism of Action

Acts as a dual amylin and calcitonin receptor agonist (AMYR/CTR) in the area postrema, creating a complementary satiety signal that acts synergistically alongside GLP-1/GIP receptor agonists.

💉 Research Dosage & Reconstitution Standard

Requires pharmaceutical-grade 0.9% benzyl alcohol Bacteriostatic Water to inhibit bacterial replication for multi-dose access.

Full Step-by-Step Guide →
Standard Vial Sizes
5mg, 10mg
Target Research Dose
0.16mg to 0.3mg weekly titrating up to 1.2mg - 2.4mg weekly
Administration Frequency
Once weekly
💧 Dilution Standard: Reconstitute with sterile Bacteriostatic Water for Injection (USP). Aim stream gently along the vial glass wall to avoid foaming. Store reconstituted solution at 2°C to 8°C (36°F to 46°F) protected from light. Discard multi-dose punctured vials at 28 days pursuant to USP <797> standards. Never freeze reconstituted liquid.

⚠️ Contraindications & Documented Adverse Effects

Strict Contraindications

  • Severe gastroparesis
  • Known allergy to amylin analogs

Documented Side Effects

  • Nausea
  • Early fullness / abdominal discomfort
  • Vomiting
  • Constipation

📚 Peer-Reviewed References & Authoritative Sources

Citations indexed in PubMed, National Center for Biotechnology Information (NCBI), and ClinicalTrials.gov.

1 VERIFIED CITATIONS
The Lancet (2021; 398:2160-2172)
Long-acting acylated amylin analogue demonstrating potent dose-dependent weight loss (up to 10.8% as monotherapy) via hypothalamic satiety centers.
PMID: 34813735 · DOI: 10.1016/S0140-6736(21)01751-7

Explore Related Research Modules

Access exact dilution guides, syringe unit calculators, and purity certificates for Cagrilintide.

💧 Cagrilintide Dilution Guide ⚡ Syringe Reconstitution Tool Bacteriostatic Water Monograph Tested Vendor Directory Cycle Cost Calculator